Houston talk. Take it with you.Free KSEV Radio appGet for iPhoneGet for Android
Skip to content
KSEV 700 AM KSEV 700 AMThe Voice of Texas

FROM SRN NEWS

AstraZeneca partners with Oracle for AI-driven clinical trials

SHARE X Facebook

Oct 20 (Reuters) – AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other measures, as the drugmaker looks to improve clinical research.

• The collaboration will combine AstraZeneca’s drug development expertise with Oracle’s AI and healthcare data capabilities to support patient matching and research

• Initial work will focus on cancer, cardiovascular, respiratory, immunology and rare diseases, and could also support earlier diagnosis of serious diseases

• The first project will support hypertension research in Abu Dhabi in partnership with UAE-based healthcare firm M42

• Patient recruitment remains one of the biggest challenges in clinical research, with delayed enrolment often extending trial timelines and increasing development costs

• Incorrect trial designs have also hurt AstraZeneca in the past, with delays on its breast cancer drug and nerve disorder treatment failure causing some worries

• AstraZeneca is seeking to expand its medicine portfolio as it targets over $80 billion in annual revenue by 2030, and works to address industry bottlenecks in drug development

(Reporting by Atharva Singh and Pushkala Aripaka in Bengaluru; Editing by Priyanka G)

Brought to you by www.srnnews.com

SRN News — View the original story at SRNNews.com.

LIVE The Dana Show Tap play to listen
0:00 0:00
Show